Search

everythinglearnresearchcommunity

for

Search:↓

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Homeopathic and biochemic treatments led to hair regrowth and improved confidence in a man with hair loss.

The food supplement with L-cystine, Serenoa repens extract, and biotin safely reduced hair loss and improved hair growth in men and women.

Smoking linked to hair loss in Asian men.

Teen hair loss common in boys, linked to family history and mild symptoms.

Researchers created a new system to classify male baldness, finding six types and a common hairline shape, to improve hair loss treatments.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

The method for sideburn reconstruction was safe and effective, giving natural-looking hair with minimal scarring.

A 10% MSC secretome hair tonic best promotes hair growth in alopecia.

AI improves accuracy and consistency in diagnosing male pattern hair loss.

Rigenera® effectively improves hair condition in Androgenetic Alopecia, and HairMetrix® tracks progress well.

Selenzin Peptide Active can effectively treat hair loss in postmenopausal women.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Camouflaging agents like hair fibers and wigs significantly improve appearance and self-esteem for most hair loss patients.